UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies. This funding will allow the two institutions to continue their collaborative efforts to create innovative technologies that can be used in the comfort of patients' homes or at the point-of-care. The aim is to improve access to healthcare and empower individuals to take control of their own health. Home-based and point-of-care technologies have the potential to transform healthcare by providing convenient and cost-effective solutions for monitoring and managing various health conditions. These technologies allow patients to track their vital signs, receive real-time feedback, and communicate with healthcare providers remotely. The renewed support from the NIH will enable UMass Chan and UMass Lowell to further enhance their existing technologies and develop new ones that address the evolving needs of patients and healthcare professionals. The funding will also support research and training programs that promote interdisciplinary collaboration and the translation of research findings into practical applications. One of the key focus areas of the initiative is the development of wearable sensors and devices that can monitor patients' health in real-time. These devices can be integrated into a wide range of wearable accessories, such as watches, bands, or patches, making them convenient and non-intrusive. By continuously monitoring vital signs, such as heart rate, blood pressure, and oxygen levels, these devices can detect and alert patients and healthcare providers of any abnormalities or potential health risks. The use of wearable sensors and devices also enables remote patient monitoring, which is particularly beneficial for individuals with chronic conditions or those who require regular medical supervision. With the ability to transmit data to healthcare professionals in real-time, remote patient monitoring allows for early intervention and timely adjustments to treatment plans, reducing hospital admissions and improving overall health outcomes. Another important aspect of the initiative is the development of diagnostics and testing technologies that can be used at the point-of-care. These technologies aim to provide rapid and accurate results, eliminating the need for laboratory testing and reducing waiting times for patients. By bringing testing capabilities closer to the patient, healthcare providers can make prompt decisions on treatment options and provide immediate care. The funding from the NIH will also support the development of telehealth and telemedicine technologies, which enable remote consultations and virtual healthcare services. These technologies have become increasingly important during the COVID-19 pandemic, as they allow patients to receive healthcare without the need for in-person visits, reducing the risk of exposure to infectious diseases. The collaborative efforts between UMass Chan and UMass Lowell have already yielded promising results. Several home-based and point-of-care technologies developed by the institutions are currently in use or undergoing clinical trials. These include a smartphone-based monitoring system for asthma management, a wearable device for detecting early signs of sepsis, and a point-of-care testing platform for diagnosing infectious diseases. The renewed support from the NIH not only validates the potential of these technologies but also provides the necessary resources to further refine and scale them. It also enables the institutions to continue advocating for policy changes and reimbursement models that promote the adoption of home-based and point-of-care technologies. The ultimate goal of the initiative is to transform healthcare and empower individuals to become active participants in their own health. By providing convenient and accessible tools for monitoring and managing health conditions, home-based and point-of-care technologies have the potential to improve healthcare outcomes, reduce healthcare costs, and enhance overall patient experiences. UMass Chan Medical School and UMass Lowell are at the forefront of this transformation, and with the renewed support from the NIH, they are poised to continue making significant contributions to the field of home-based and point-of-care health technologies. Through collaboration, research, and innovation, they are shaping the future of healthcare and paving the way for a more patient-centered and technology-driven approach.
top of page
bottom of page